President Biden announced he would bring back the Cancer Moonshot initiative that launched in the Obama administration; the World Health Organization said the Omicron subvariant, BA.2, appears to have the same severity as the original Omicron variant; cases of suicide by drug overdose increased in young people, older adults, and non-Hispanic Black women.
President Biden announced Wednesday a plan to reduce the cancer death rate by at least 50% over the next 25 years as part of his Cancer Moonshot initiative, which initially began when he was vice president in the Obama administration. The reinvigorated plan will include a campaign encouraging Americans to get screened for cancer and make up for appointments missed due to the COVID-19 pandemic. According to the American Cancer Society, an estimated 1.9 million new cancer cases and nearly 610,000 cancer deaths are expected in 2022.
As reported by Reuters, the World Health Organization (WHO) stated that the emerging subvariant of Omicron, BA.2, appears to have the same severity as the original Omicron variant, BA.1. WHO also said vaccine efficacy is similar for both the BA.1 and BA.2 viruses, however, the new subvariant has the potential to replace BA.1 globally. These findings are based on data from Denmark that showed BA.2 is more transmissible, even leading to breakthrough cases among vaccinated people, and becoming more dominant in Denmark, the Philippines, Nepal, Qatar, and India.
A study led by researchers at the National Institute on Drug Abuse (NIDA) found that, despite an overall downward trend in the United States, cases of suicide by drug overdose increased in young people aged 15 to 24, older adults aged 75 to 84, and non-Hispanic Black women in 2019. The National Institutes of Health statement said that women were overall more likely to die from intentional drug overdose than men, with the highest cases among women aged 45 to 64. These deaths also varied by time of week or year, with most intentional overdose deaths occurring on Mondays or in spring and summer, and the least deaths occurring on weekends or in December.
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Symptom Documentation Differences in Acute Cancer Care Suggest Sociodemographic Disparities
April 22nd 2025Researchers are calling for more targeted efforts to improve health equity after a new analysis revealed that cancer symptom documentation and burden vary across certain demographics.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen